📰 Alkermes News
Page 10 - Alkermes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alkermes. Real-time updates on events, politics, business and more.
January 31, 2024
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The
January 31, 2024
Alkermes plc (NASDAQ:ALKS – Get Free Report) was the recipient of a significant decline in short interest in the month of January. As of January 15th, there was short interest totalling 13,230,000 shares, a decline of 5.6% from the December 31st total of 14,020,000 shares. Based on an average trading volume of 2,630,000 shares, the […]
January 28, 2024
Treatment with adjuvant pembrolizumab significantly improved overall survival vs placebo in patients with clear cell renal cell carcinoma.
January 28, 2024
The Danish pharma giant said up to 2,000 workers will be employed during the construction…
January 28, 2024
Local residents have voiced concern about plans for an estimated €2 billion expansion of its Irish operations by a leading pharmaceutical firm seeking to increase production of its best-selling weight loss and diabetes medicines.
January 28, 2024
The Danish pharma giant said up to 2,000 workers will be employed during the construction phase
January 28, 2024
The Danish pharma giant said up to 2,000 workers will be employed during the construction…
January 28, 2024
The Danish pharma giant said up to 2,000 workers will be employed during the construction…
January 28, 2024
The Danish pharma giant said up to 2,000 workers will be employed during the construction…
January 27, 2024
Alkermes (ALKS) closed the most recent trading day at $27.74, moving -1% from the previous trading session.